Evidence map›Paper›PMID 34631726›Full record

ArticleFrontiers in medicine2021

Case Report: Diagnostic Value of Metagenomics Next Generation Sequencing in Intracranial Infection Caused by Mucor.

YuChen Liu, Jun Zhang, Bing Han, LiJuan Du, ZhaoYang Shi, ChunCheng Wang, Min Xu, YongGang Luo

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Metagenomic next-generation sequencing: new horizons in microbiology.Frontiers in cellular and infection microbiology · 2026
    Review
  3. Review
  4. Article
  5. Frontiers in cellular and infection microbiology · 2023
    Article
  6. Article
  7. Article
  8. Invasive splenic mucormycosis due toFrontiers in oncology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The diagnostic value of metagenomic next-generation sequencing for identifyingFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

YuChen LiuDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jun ZhangDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bing HanDepartment of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
LiJuan DuDepartment of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ZhaoYang ShiDepartment of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ChunCheng WangDepartment of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Min XuDepartment of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
YongGang LuoDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

mNGS(metagenomics Next Generation Sequencing), as a novel culture-independent approach, demonstrated the capability of rapid, sensitive, and accurate pathogen identification. At present, there have been many case reports about the use of mNGS to assist in the diagnosis of bacterial, fungal, viral and parasitic infections and to guide clinicians to determine appropriate treatment. However, the clinical understanding of this technique is not comprehensive, and the experience of using it is relatively limited. We reported a 53-year-old man who was admitted to hospital with a high fever and headache. His inflammatory biomarkers were markedly elevated. Based on the clinical presentation, He was initially diagnosed as having an intracranial infection of unknown etiology and received empirical antibiotics and systemic supportive treatment. But these did not relieve his symptoms. Both the blood and CSF specimens were examined using traditional culture, serological testing, and mNGS. Traditional culture and serological testing produced negative results, while the mNGS revealed the presence of a potential pathogen,

Indexed as

intracranial infectionLichtheimia ramosametagenomics Next Generation Sequencingmucormycosisprecision treatment

Identifiers

PMID34631726
PMCPMC8494775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.